Webcasts – IVHEM 2016

 

Hirnschall, Gottfried 2016

Opening lecture on WHO programs
Gottfried Hirnschall
Head, HIV/Viral Hepatitis Department, World Health Organization, USA

  Session 1: Results of National programs: Barriers & Successes
 

Hatzakis, Angelos 2015 120

National perspectives in Europe - common themes and challenges
Angelos Hatzakis
Professor of Epidemiology and Preventive Medicine, Athens University Medical School, Athens Greece & Co-Chair, Hepatitis B and C Public Policy Association

 

Urbanus, Anouk 120x160

National Programs - the Netherlands
Anouk Urbanus 

‎Policy Advisor Infectious Diseases, National Institute of Public Health and the Environment, Bilthoven, the Netherlands

 

Doss, Wahid 2016 120

National Programs - Egypt (coming soon)
Wahid Doss 
Professor, Cairo University, Cairo, Egypt & Head, National Committee for Control of Viral Hepatitis, Egypt

 

Hellard, Margaret 2015_2

National Programs - Australia
Margaret Hellard
Head, Centre for Population Health, Burnet Institute, Melbourne, Australia

 

Ward, John 2015_120

National Programs - US
John Ward
Director, Viral Hepatitis Program, Centers of Disease Control and Prevention, Atlanta, USA

 Discussion
  Session 2: Progress towards elimination - Specific Populations
 

Lloyd, Andrew 2016 120

Progress towards elimination in the Australian prison sector
Andrew Lloyd 
Infectious Diseases Physician & Prisoner Health Researcher, Kirby Institute, University of New South Wales, and Justice Health & Forensic Mental Health Network, Sydney, Australia

 

El-Sayed, Manal 2014

Children & Pregnant women
Manal El-Sayed
Professor of Pediatrics, Ain Shams University, Cairo, Egypt

 

Dalgard, Olav web 120

People who inject drugs
Olav Dalgard
Professor of Infectious Diseases, Åkershus University Hospital, Lørenskog, Norway

 Discussion
  Session 3: Diagnosing
 

Hellard, Margaret 2015_2

WHO Guidelines and Policies of testing
Margaret Hellard
Head, Centre for Population Health, Burnet Institute, Melbourne, Australia

 

Donchuk, Dmytro 120

Progess in testing technologies
Dmytro Donchuk
Infectious Diseases Specialist, HIV, TB and Viral Hepatitis Adviser, Médecins Sans Frontières, Brussels, Belgium

 

Andrieux-Meyer, Isabelle 2016 120

Challenges in Monitoring (POC)
Isabelle Andrieux-Meyer
HIV/HCV Team Lead, Drugs for Neglected Diseases initiative, Frontières, Geneva, Switzerland

 

Nelson, Mark 2012_120

Challenges in regards to resistance
Mark Nelson
Consultant Physician, Chelsea and Westminster Hospital, London, United Kingdom

  Session 4: Reducing Transmission and harm
 

Altaf, Arshad 120

Global Injection Safety Campaign and Prevention Strategies
Arshad Altaf 

Consultant Injection Safety, World Health Organization, Geneva, Switzerland

 

Vickerman, Peter 2016 120

Can we afford not to treat reinfection (not available)
Peter Vickerman
Professor of Infectious Disease Modelling, University of Bristol, Bristol, United Kingdom

 

Sarang, Anya 120

Creating awareness and sharing the knowledge
Anya Sarang
Director, Andrey Rylkov Foundation for Health and Social Justice, Moscow, Russia

 

Schatz, Eberhard 2016 120

Community and harm reduction response to infection and reinfection
Eberhard Schatz
Coordinator European Initiative on Hepatitis C and Drug Use, Correlation Network c/o Foundation De Regenboog Groep, Amsterdam, the Netherlands

 Discussion
  Session 5: Future scenarios for elimination
 

Cox, Andrea 2016 120

Vaccine development and results
Andrea Cox 
Professor of Medicine, Johns Hopkins School of Medicine Baltimore, MD, USA

 

Feld, Jordan 2016 120

Minimising treatment duration and doses
Jordan Feld
Research Director and Clinician-Scientist, Toronto Centre for Liver Disease, Toronto, Canada

 

Hill, Andrew 2016

Role of generic drugs
Andrew Hill
Senior Visiting Research Fellow, Liverpool University, Liverpool, UK

 

Walhof, Pieter 2016 120

Financial models for high- and low income countries
Pieter Walhof
Director PharmAccess and Health Insurance Fund, PharmAccess Foundation, Amsterdam, the Netherlands

 

Vella, Stefano 2012 120x160

Building global capacity
Stefano Vella
Chair of Global Health, Istituto Superiore di Sanità

 Round table discussion

 <<Go back the IVHEM 2016 website